missing translation for 'onlineSavingsMsg'
Learn More
Learn More
SB 202190, MedChemExpress
Click to view available options
Quantity:
50 mg
100 mg
200 mg
Unit Size:
100mg
200mg
50mg
Description
SB 202190 is a selective p38 MAP kinase inhibitor with IC50s of 50 nM and 100 nM for p38α and p38β2, respectively. SB 202190 binds to the ATP pocket of the active recombinant human p38 kinase with a Kd of 38 nM. SB 202190 has anti-cancer activity and rescued memory deficits. SB202190 induces autophagy.
Specifications
Specifications
| Chemical Name or Material | SB 202190 |
| CAS | 152121-30-7 |
| Color | Light Nude |
| Purity Grade Notes | Research |
| Molecular Formula | C20H14FN3O |
| Quantity | 200 mg |
| Solubility Information | DMSO : 100 mg/mL (301.80 mM; Need ultrasonic) |
| SMILES | FC1=CC=C(C2=C(C3=CC=NC=C3)NC(C4=CC=C(O)C=C4)=N2)C=C1 |
| Molecular Weight (g/mol) | 331.34 |
| Formula Weight | 331.34 |
| Show More |
Research purposes only
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction